Literature DB >> 21269811

In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.

Meng-Shuian Hsu, Chun-Hsing Liao, Chia-Ying Liu, Chia-Jui Yang, Yu-Tsung Huang, Po-Ren Hsueh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269811     DOI: 10.1016/j.ijantimicag.2010.12.003

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  13 in total

1.  Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China.

Authors:  Jianxia Hou; Xianhui Huang; Yuting Deng; Liangying He; Tong Yang; Zhenling Zeng; Zhangliu Chen; Jian-Hua Liu
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 2.  Antibiotics in the clinical pipeline at the end of 2015.

Authors:  Mark S Butler; Mark At Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

3.  Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011.

Authors:  Chun-Ming Lee; Chun-Hsing Liao; Wen-Sen Lee; Yung-Ching Liu; Jung-Jung Mu; Meng-Chih Lee; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

4.  Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones.

Authors:  Zhaoxia Li; Youning Liu; Rui Wang; Aimin Li
Journal:  World J Microbiol Biotechnol       Date:  2014-08-18       Impact factor: 3.312

Review 5.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

6.  Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.

Authors:  Ryota Ito; Adam D Tomich; Christi L McElheny; Roberta T Mettus; Nicolas Sluis-Cremer; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

7.  Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.

Authors:  Martin Kaase; Florian Szabados; Agnes Anders; Sören G Gatermann
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

Review 8.  Review of nemonoxacin with special focus on clinical development.

Authors:  Xiaohua Qin; Haihui Huang
Journal:  Drug Des Devel Ther       Date:  2014-07-05       Impact factor: 4.162

Review 9.  Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis.

Authors:  George G Zhanel; Andrew J Walkty; James A Karlowsky
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-05-10       Impact factor: 2.471

10.  Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene.

Authors:  Ryota Ito; Mustapha M Mustapha; Adam D Tomich; Jake D Callaghan; Christi L McElheny; Roberta T Mettus; Robert M Q Shanks; Nicolas Sluis-Cremer; Yohei Doi
Journal:  mBio       Date:  2017-08-29       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.